Italy moves to address prenatal diagnostics failings
This article was originally published in Clinica
The Italian government has acknowledged the need to significantly improve the quality, speed and level of access to routine prenatal diagnostics services. A summary of the key issues stemming from a 2007 report on the situation has been published by the health ministry ahead of the March 6 meeting of the "state-regions conference".
You may also be interested in...
Grail announced it will enroll about 6,200 people in an interventional, multi-center study evaluating its multi-cancer early-detection blood test. This is the first time health care providers will use this test to help guide patient care.
As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.
Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.